ENVALITH
積水化学工業株式会社 logo

SEKISUI CHEMICAL CO.,LTD.

4204Prime MarketChemicals

積水化学工業株式会社 logo
SEKISUI CHEMICAL CO.,LTD.4204

Business

Sekisui Chemical Co., Ltd., founded in 1947, is a comprehensive plastics manufacturer that currently operates four business segments: Housing Business (steel-frame and wood-based unit housing, remodeling, residential), Environment & Living Infrastructure Business (social infrastructure materials such as pipes, pipe rehabilitation, and synthetic wood), High Performance Plastics Business (semiconductor materials, interlayer film for laminated glass, aircraft composite materials, etc.), and Medical Business (clinical diagnostic reagents, pharmaceutical APIs). The company has 168 consolidated subsidiaries and 13 affiliated companies both in Japan and overseas, with net sales of ¥1,309,281 million. Its major customers span a wide range, including home buyers, construction companies, semiconductor manufacturers, automakers, and medical institutions, and it operates its business with "Creating Infrastructure for Housing and Society" and "Chemical Solutions" as its two core pillars.

Business Model

In the Housing Business, factory-produced units are delivered through the company's own sales and construction network, generating recurring revenue after completion through remodeling, rental management, and real estate services. The Environment & Living Infrastructure Business provides an integrated offering from pipe material manufacturing to pipeline rehabilitation methods, capturing demand for renewal of aging infrastructure. The High Performance Plastics Business leverages proprietary materials and processing technologies to sell high-value-added products globally for semiconductor, automotive, and aircraft applications. The Medical Business provides diagnostic reagents, equipment, and APIs in an integrated manner, securing stable revenue through ongoing transactions with medical institutions. The diversified structure of these four segments mitigates the risk of economic fluctuations.

Company Strengths

High Performance Plastics reported net sales of ¥456,575 million and operating income of ¥59,325 million (margin of approximately 13%). The business has established a four-region global sales structure—North America ¥118,076 million, Europe ¥81,050 million, China ¥76,026 million, and Asia ¥52,403 million—for proprietary materials such as semiconductor microparticles, interlayer film for laminated glass, and aircraft CFRP composites. This combination of technology and sales channels, which competitors find difficult to replicate in the short term, underpins the earnings base.

Operating income for the Environment & Living Infrastructure Business reached ¥23,247 million, marking a record high for the fourth consecutive period. In addition to thorough domestic spread management, the company's proprietary product and construction method portfolio—including expanded adoption of synthetic wood (FFU) sleepers in Europe, larger-diameter and overseas expansion of the SPR pipe rehabilitation method, and increased adoption of fire-resistant and non-combustible materials—is driving sustained earnings improvement.

The Housing Business posted net sales of ¥535,944 million and operating income of ¥37,150 million (up 17.9% year on year). Despite a decline in the number of units, the shift in mix toward multi-family housing and higher-priced detached houses raised the average unit price. Remodeling orders reached 105% of the previous period's level, and the number of managed rental units continued to increase steadily. Large-scale remodeling orders originating from regular inspections, together with expansion of resale of purchased properties, are contributing to margin improvement through a recurring revenue model generated after completion of construction.

ENVALITH's Perspective

Net income attributable to owners of the parent for FY2026 (ending March 2026) decreased to ¥75,174 million (-8.2% YoY). The main factors were impairment losses totaling ¥23,302 million, including the withdrawal from the ethanol conversion plant in Kuji City, Iwate Prefecture (¥14,891 million), intangible fixed assets in the U.S. diagnostic reagents business (¥3,871 million), and the UK enzyme and pharmaceutical development business (¥2,420 million in total). On the other hand, ordinary income reached a record high of ¥117,215 million, aided by a contribution of ¥4,749 million in foreign exchange gains, indicating that underlying operating performance remains solid. The focus of evaluation will be on the recovery of net income once the impact of the impairment losses has passed.

The company's forecast for FY2027 (ending March 2027) calls for net sales of ¥1,408,400 million (+7.6%) and operating profit of ¥115,000 million (+8.0%), an aggressive plan. Revenue and profit growth is expected across all segments, led by High Performance Plastics (operating profit of ¥64,500 million, +8.7%) and Housing (¥40,000 million, +7.7%). On the other hand, ordinary income is projected to decline to ¥114,000 million (-2.7%), reflecting the absence of the prior period's foreign exchange gains. While the assumed USD rate of ¥155 (versus the actual rate of ¥146) may appear conservative given the yen-appreciation direction, attention should be paid to the potential impact of geopolitical risks, such as the situation in the Middle East, on raw material procurement.

The "Others" segment recorded an operating loss of ¥12,710 million in FY2026 (ending March 2026), reflecting continued upfront investment in the Film-type Perovskite Solar Cell (SOLAFIL). In March 2026, the company established a 1-meter-wide manufacturing technology and metal roof installation specifications, initiating commercialization, and has designated the launch of a 100MW production line in FY2027 as its top priority. While tailwinds are expected in the market environment as a next-generation energy business, technical and cost risks associated with scaling up commercialization remain. Disclosure of the business's positioning and investment scale in the new medium-term management plan (scheduled for announcement in May 2026) will affect the equity valuation.

Growth Strategy

Under Vision 2030 and the new mid-term management plan, the company aims to double its business scale through expanded sales of high-value-added products, creation of new businesses, and strengthened ESG management

Promoting acquisition of new customers and new applications for semiconductor and display materials, expanded sales of interlayer film for head-up displays, and development of new fields such as aircraft and drones. For FY2027 (ending March 2027), the company plans record-high operating income of ¥64,500 million (+8.7%). Increases in tangible and intangible fixed assets reached ¥32,277 million in FY2026 (ending March 2026), reflecting continued aggressive investment.

Promoting an increase in per-unit prices through a shift in composition toward multi-family housing and high-priced detached houses, strengthening the product menu centered on insulation remodeling and expanding external sales orders (next plan: order volume at 105% of the previous period), and expanding the scale of the Residential Business through an increase in the number of managed rental units and expansion of buy-and-resell operations. For FY2027 (ending March 2027), the company plans orders at 102% of the previous period in units and 103% in value.

Promoting expanded adoption of synthetic wood (FFU) railway sleepers in Europe and expansion into the US market, capturing domestic demand for renewal of aging pipeline infrastructure and expanding overseas orders for pipe renewal, and promoting expanded sales of new CPVC resin products and expansion of sales areas. The company aims to achieve record profits for a fifth consecutive period by offsetting increased fixed costs from human capital investment and other factors through higher overseas sales and securing spreads.

Established one-meter-wide manufacturing technology and metal roof installation specifications in March 2026, beginning commercialization. Top priority is placed on expanding supply capacity through the launch of a 100MW production line in fiscal 2027. Promoting market development for locations where installation of conventional solar cells is difficult, leveraging the lightweight and flexible characteristics of the product.

Having completed the final year of the mid-term management plan "Drive2.0" (FY2024 (ending March 2024) to FY2026 (ending March 2026)), the company plans to announce a new mid-term management plan in May 2026. As Phase 3 of the long-term vision "Vision 2030," the company will continue the three pillars of strategic creation, strengthening existing businesses, and strengthening the ESG management foundation, aiming to double its business scale by 2030. As part of governance enhancement, the company has also implemented an organizational change separating Company Presidents from the Board of Directors so that they can focus on execution.

Last updated: July 19, 2026